Focera

Monitoring and localized ablation

A new approach
to glioblastoma.

Focera is developing wireless implants designed to monitor disease progression and deliver localized ablation. Bringing those capabilities together could help care teams see changes sooner and respond more precisely.

01 / MONITOR

Monitor disease progression.

Explore a clearer view of disease progression through implant-based monitoring.

02 / TARGET

Deliver localized ablation.

Develop wireless, localized ablation focused on the tumor environment.

03 / CONNECT

Combine monitoring and treatment.

Pair monitoring and intervention in a single device-led approach.

Our scientific focus

Beyond the limits of pharmacological response.

Glioblastoma often resists conventional pharmacological approaches, with limited immune response in the local tumor environment. Focera is exploring a device-led approach that pairs monitoring with wireless, targeted ablation.

Stay connected

Connect with Focera.

If you’re an investor, clinician, researcher, or potential collaborator, you can sign up for updates on our research and development.

We’ll only use your details to share relevant updates from Focera.